Mergers, acquisitions, strategic partnerships, and product licensing. Plus, strategies and tactics for better deal-making
 | December 1, 2011
By:Ben Comer
It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle?
 |
October 1, 2011
Top 10 Companies by Market Share
|
October 1, 2011
Top 10 Products Worldwide
|
October 1, 2011
30 Years of Pharma: Perspective in Numbers
|
 | September 1, 2011
By:Bill Trombetta
Bill Trombetta surveys the landscape of pharma financials over the past year, and shows which companies rode the wave to the top of the industry in delivering value to shareholders.
|
July 1, 2011
By:Todd C. Davis
Structuring a good deal depends on understanding your partner—and a high degree of specificity
|
June 1, 2011
Part II of The Avoca Group's 2011 CRO survey on clinical development outsourcing relationships
|
 | June 1, 2011
By:William Looney
With Yankee stadium as the backdrop, Pharm Exec convened its annual panel of eight business development experts to crack the bat on best practice in licensing and M&A for the year ahead.
|
May 5, 2011
By:Rich Whitworth
Israel-based Teva Industries seals deal to acquire Cephalon for $6.8 billion.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
